Peter Soparkar insider trades
Open-market stock purchases and sales by Peter Soparkar, CHIEF OPERATING OFFICER at Adverum Biotechnologies, Inc, from SEC Form 4 filings since Oct 30, 2019.
Track record: 75% of 4 scored buys are up 5% or more since purchase, averaging +126%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $460K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $331K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $406K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Bought (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $162K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $390K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $400K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $41.3K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $142K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $456K |
| Dec 5, 2025 | ADVM Adverum Biotechnologies, Inc | Bought | $211K |
Companies traded
- ADVM Adverum Biotechnologies, Inc: 5 buys, 3 sales, last Dec 9, 2025